Bioxcel therapeutics announces reverse stock split

New haven, conn., feb. 06, 2025 (globe newswire) -- bioxcel therapeutics, inc. (nasdaq: btai), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that it will effect a 1-for-16 reverse stock split of its common stock. the reverse stock split will become effective at 5:00 p.m. eastern time on february 7, 2025, with the company's common stock expected to begin trading on a split-adjusted basis at the opening of the market on monday, february 10, 2025.
BTAI Ratings Summary
BTAI Quant Ranking